ADAR1 Capital Management’s PureTech Health PRTC Stock Holding History

ADAR1 Capital Management’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,000	Closed	-$61.8K	–	288
2024 Q3	$61.8K	Buy	3,000 +2,300	+329%	+$50.3K	0.01%	205
2024 Q2	$17.5K	Buy	+700	New	+$19.6K	﹤0.01%	224

Other funds holding PRTC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.23B AUM 15.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management's PRTC Position: Q4 2024 in Review

ADAR1 Capital Management sold out of PureTech Health (PRTC) in Q4 2024, closing a stake of 3,000 shares — an estimated $61.8K sold.

ADAR1 Capital Management first reported a position in PRTC in Q2 2024 and held it in 2 quarters. The position peaked at $61.8K in Q3 2024. 5 funds tracked by Wall St. Rank hold PRTC as of Q4 2024.

ADAR1 Capital Management reported no remaining PureTech Health position as of Q4 2024 after selling out during the quarter.
ADAR1 Capital Management sold 3,000 PureTech Health shares in Q4 2024, an estimated $61.8K.
ADAR1 Capital Management first reported a position in PureTech Health in Q2 2024 and held it in 2 quarters.
ADAR1 Capital Management's PureTech Health position peaked at $61.8K in Q3 2024.
5 funds tracked by Wall St. Rank held PureTech Health as of Q4 2024.

Based on ADAR1 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.